1. Home
  2. EH vs NVAX Comparison

EH vs NVAX Comparison

Compare EH & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EHang Holdings Limited ADS

EH

EHang Holdings Limited ADS

HOLD

Current Price

$12.03

Market Cap

846.5M

Sector

Industrials

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$10.09

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EH
NVAX
Founded
2014
1987
Country
China
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
846.5M
1.6B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
EH
NVAX
Price
$12.03
$10.09
Analyst Decision
Strong Buy
Hold
Analyst Count
4
9
Target Price
$21.85
$11.33
AVG Volume (30 Days)
494.7K
4.2M
Earning Date
01-01-0001
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
309.76
EPS
N/A
2.58
Revenue
N/A
$1,123,479,000.00
Revenue This Year
$10.53
N/A
Revenue Next Year
$81.37
N/A
P/E Ratio
N/A
$3.97
Revenue Growth
N/A
64.69
52 Week Low
$11.07
$5.01
52 Week High
$25.48
$11.85

Technical Indicators

Market Signals
Indicator
EH
NVAX
Relative Strength Index (RSI) 48.03 55.12
Support Level $11.15 $7.81
Resistance Level $12.80 $10.42
Average True Range (ATR) 0.55 0.73
MACD 0.07 -0.02
Stochastic Oscillator 39.08 36.18

Price Performance

Historical Comparison
EH
NVAX

About EH EHang Holdings Limited ADS

EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: